https://news.medxy.ai/zh/esophageal-leak-survival/Medxy AIzh2026-09-11T09:33:50-07:00食管切除术后重度吻合口漏对长期生存的影响：现代多中心队列研究的新证据 https://news.medxy.ai/ja/anastomotic-leak-impact/Medxy AIja2026-09-11T09:33:32-07:00食道切除術後の重症吻合部漏出は長期予後をどう変えるか：最新多施設コホートからの知見 https://news.medxy.ai/vi/72695-2/Medxy AIvi2026-09-11T09:33:11-07:00Tình trạng rò miệng nối nghiêm trọng sau phẫu thuật cắt thực quản ảnh hưởng như thế nào đến tiên lượng dài hạn? https://news.medxy.ai/impact-of-severe-anastomotic-leak-after-esophagectomy-on-long-term-survival-insights-from-a-modern-multicenter-cohort/Medxy AIen2026-09-11T09:32:50-07:00Impact of Severe Anastomotic Leak After Esophagectomy on Long-Term Survival: Insights from a Modern Multicenter Cohort https://news.medxy.ai/zh/global-hospital-infrastructure-pancreatic-surgery-mortality/Medxy AIzh2026-09-11T09:32:04-07:00全球医院基础设施与胰腺手术死亡率：来自医院资源指数的启示 https://news.medxy.ai/ja/hospital-resource-index/Medxy AIja2026-09-11T09:31:44-07:00膵臓手術後死亡率を左右する病院インフラとは？ Hospital Resource Indexが示す世界的エビデンス https://news.medxy.ai/vi/global-hospital-infrastructure/Medxy AIvi2026-09-11T09:31:19-07:00Cơ sở hạ tầng bệnh viện trên toàn cầu và tác động đến tử vong sau phẫu thuật tụy: Góc nhìn từ Chỉ số Tài nguyên Bệnh viện https://news.medxy.ai/global-hospital-infrastructure-and-its-impact-on-mortality-after-pancreas-surgery-insights-from-the-hospital-resource-index/Medxy AIen2026-09-11T09:30:59-07:00Global Hospital Infrastructure and Its Impact on Mortality After Pancreas Surgery: Insights from the Hospital Resource Index https://news.medxy.ai/zh/p53-interferon-pathway/Medxy AIzh2026-09-11T09:30:13-07:00p53 突变如何重塑子宫内膜癌中的 I 型干扰素通路：免疫调控新视角 https://news.medxy.ai/ja/p53-mutation-uterine-cancer/Medxy AIja2026-09-11T09:29:51-07:00子宮体癌における変異p53がI型インターフェロン経路に及ぼす影響：免疫調節の視点 https://news.medxy.ai/vi/mutant-p53-endometrial-cancer/Medxy AIvi2026-09-11T09:29:29-07:00Tác động của p53 đột biến lên biểu hiện con đường interferon type I trong ung thư nội mạc tử cung: những góc nhìn về điều hòa miễn dịch https://news.medxy.ai/impact-of-mutated-p53-on-type-i-interferon-pathway-expression-in-endometrial-cancer-immune-modulatory-insights/Medxy AIen2026-09-11T09:29:09-07:00Impact of Mutated p53 on Type I Interferon Pathway Expression in Endometrial Cancer: Immune Modulatory Insights https://news.medxy.ai/zh/early-cervical-cancer-surgery/Medxy AIzh2026-09-11T09:28:23-07:00早期宫颈癌中不使用子宫操纵器的微创根治性子宫切除术与开腹手术：大型倾向评分匹配队列的比较结局 https://news.medxy.ai/ja/minimally-invasive-hysterectomy-3/Medxy AIja2026-09-11T09:28:00-07:00子宮マニピュレーター非使用の低侵襲根治的子宮全摘術は開腹手術に代わり得るか：早期子宮頸癌における大規模傾向スコアマッチ解析 https://news.medxy.ai/vi/minimally-invasive-hysterectomy-2/Medxy AIvi2026-09-11T09:27:36-07:00Phẫu thuật cắt tử cung tận gốc xâm lấn tối thiểu không dùng dụng cụ thao tác tử cung so với phẫu thuật mở trong ung thư cổ tử cung giai đoạn sớm: Kết cục so sánh từ một đoàn hệ lớn ghép cặp theo điểm xu hướng https://news.medxy.ai/minimally-invasive-radical-hysterectomy-without-uterine-manipulator-vs-open-surgery-for-early-stage-cervical-cancer-comparative-outcomes-from-a-large-propensity-matched-cohort/Medxy AIen2026-09-11T09:27:14-07:00Minimally Invasive Radical Hysterectomy Without Uterine Manipulator vs Open Surgery for Early-Stage Cervical Cancer: Comparative Outcomes from a Large Propensity-Matched Cohort https://news.medxy.ai/zh/maternal-plasma-biomarkers/Medxy AIzh2026-09-11T09:26:31-07:00通过大规模蛋白质组学筛查发现母体血浆新型生物标志物，提升胎儿死亡检测能力 https://news.medxy.ai/ja/fetal-death-biomarkers/Medxy AIja2026-09-11T09:26:12-07:00胎児死亡の検出をさらに高精度に：大規模プロテオミクス解析で見いだされた新規母体血漿バイオマーカー https://news.medxy.ai/vi/stillbirth-biomarkers/Medxy AIvi2026-09-11T09:25:49-07:00Mở rộng khả năng phát hiện thai chết lưu: Xác định các biomarker mới trong huyết tương mẹ bằng phân tích proteomic quy mô lớn https://news.medxy.ai/advancing-fetal-death-detection-identification-of-novel-maternal-plasma-biomarkers-through-large-scale-proteomic-profiling/Medxy AIen2026-09-11T09:25:29-07:00Advancing Fetal Death Detection: Identification of Novel Maternal Plasma Biomarkers Through Large-Scale Proteomic Profiling https://news.medxy.ai/zh/vulvar-cancer-recurrence/Medxy AIzh2026-09-11T09:24:39-07:00外阴癌复发：发病率、生存与症状学——基于人群队列研究和最新证据的洞察 https://news.medxy.ai/ja/vulvar-cancer-recurrence-2/Medxy AIja2026-09-11T09:24:10-07:00外陰がん再発の発生率・生存・症状を読み解く：集団ベース研究と最新エビデンスからの知見 https://news.medxy.ai/vi/72646-2/Medxy AIvi2026-09-11T09:23:44-07:00Ung thư âm hộ tái phát: Tỷ lệ mắc, tỷ lệ sống còn và triệu chứng lâm sàng https://news.medxy.ai/incidence-survival-and-symptomatology-of-recurrence-in-vulvar-cancer-insights-from-population-based-cohort-studies-and-contemporary-evidence/Medxy AIen2026-09-11T09:23:19-07:00Incidence, Survival, and Symptomatology of Recurrence in Vulvar Cancer: Insights from Population-Based Cohort Studies and Contemporary Evidence https://news.medxy.ai/zh/gerd-burping-features/Medxy AIzh2026-09-11T09:21:51-07:00明确性 GERD 中过度性食管上嗳气的临床特征与预测因素揭秘 https://news.medxy.ai/ja/72640-2/Medxy AIja2026-09-11T09:21:28-07:00GERDにおける過剰な胃上部げっぷの臨床的特徴および予測因子の解明 https://news.medxy.ai/vi/excessive-belching-gerd/Medxy AIvi2026-09-11T09:21:09-07:00Nhận diện ợ hơi trên dạ dày quá mức trong GERD xác định rõ: các dấu ấn lâm sàng và yếu tố dự báo https://news.medxy.ai/unveiling-excessive-supragastric-belching-in-conclusive-gerd-clinical-insights-and-predictors/Medxy AIen2026-09-11T09:20:49-07:00Unveiling Excessive Supragastric Belching in Conclusive GERD: Clinical Insights and Predictors https://news.medxy.ai/ja/ischemic-stroke-burden/Medxy AIja2026-09-11T09:20:01-07:00糖尿病と心房細動に起因する虚血性脳卒中負担の世界動向：糖尿病関連負担の拡大 https://news.medxy.ai/vi/global-ischemic-stroke-burden/Medxy AIvi2026-09-11T09:19:38-07:00Xu hướng toàn cầu về gánh nặng đột quỵ thiếu máu cục bộ do đái tháo đường so với rung nhĩ https://news.medxy.ai/global-trends-in-the-burden-of-ischemic-stroke-attributable-to-diabetes-versus-atrial-fibrillation/Medxy AIen2026-09-11T09:19:15-07:00Global Trends in the Burden of Ischemic Stroke Attributable to Diabetes Versus Atrial Fibrillation https://news.medxy.ai/zh/72628-2/Medxy AIzh2026-09-11T08:50:45-07:00吸烟、呼出气一氧化碳与帕金森病发病有关 https://news.medxy.ai/ja/smoking-co2-parkinsons-risk/Medxy AIja2026-09-11T08:50:23-07:00喫煙・呼気一酸化炭素・パーキンソン病リスクの関係：疫学的知見と機序的考察 https://news.medxy.ai/vi/smoking-carbon-monoxide-parkinson/Medxy AIvi2026-09-11T08:49:58-07:00Hút thuốc, carbon monoxide trong khí thở ra và nguy cơ bệnh Parkinson: Góc nhìn dịch tễ học và cơ chế sinh học https://news.medxy.ai/smoking-exhaled-carbon-monoxide-and-parkinsons-disease-risk-epidemiological-insights-and-mechanistic-perspectives/Medxy AIen2026-09-11T08:49:35-07:00Smoking, Exhaled Carbon Monoxide, and Parkinson’s Disease Risk: Epidemiological Insights and Mechanistic Perspectives https://news.medxy.ai/ja/mc1r-parkinsons-progress/Medxy AIja2026-09-11T08:48:29-07:00MC1R一般変異とパーキンソン病進行の関連 https://news.medxy.ai/vi/mc1r-variants-parkinson/Medxy AIvi2026-09-11T08:48:09-07:00Các biến thể MC1R thường gặp và tiến triển bệnh Parkinson https://news.medxy.ai/common-mc1r-variants-and-parkinson-disease-progression/Medxy AIen2026-09-11T08:47:52-07:00Common MC1R Variants and Parkinson Disease Progression https://news.medxy.ai/zh/freestyle-libre-pro-iq/Medxy AIzh2026-09-11T08:47:03-07:00FreeStyle Libre Pro iQ 连续葡萄糖监测在症状前1型糖尿病中的应用：早期识别与风险分层的新进展 https://news.medxy.ai/ja/freestyle-libre-pro-monitoring/Medxy AIja2026-09-11T08:46:44-07:00FreeStyle Libre Pro iQによる持続血糖モニタリング：症候出現前1型糖尿病における早期発見とリスク層別化の新展開 https://news.medxy.ai/vi/continuous-glucose-monitoring/Medxy AIvi2026-09-11T08:46:21-07:00Theo dõi glucose liên tục bằng FreeStyle Libre Pro iQ ở đái tháo đường týp 1 tiền triệu chứng: Tiến bộ trong phát hiện sớm và phân tầng nguy cơ https://news.medxy.ai/continuous-glucose-monitoring-using-the-freestyle-libre-pro-iq-in-presymptomatic-type-1-diabetes-advancements-in-early-detection-and-risk-stratification/Medxy AIen2026-09-11T08:45:58-07:00Continuous Glucose Monitoring Using the FreeStyle Libre Pro iQ in Presymptomatic Type 1 Diabetes: Advancements in Early Detection and Risk Stratification https://news.medxy.ai/zh/autism-transgender-hormones/Medxy AIzh2026-09-11T08:45:00-07:00孤独症跨性别与性别多样化成人的性别肯定激素治疗：依从性挑战与优化策略 https://news.medxy.ai/ja/gender-affirming-hormone-therapy/Medxy AIja2026-09-11T08:44:37-07:00自閉症のあるトランスジェンダー・性別多様成人におけるジェンダー肯定的ホルモン療法：アドヒアランス最適化に向けた課題と方策 https://news.medxy.ai/vi/hormone-treatment-autism/Medxy AIvi2026-09-11T08:44:12-07:00Điều trị hormone khẳng định giới ở người trưởng thành chuyển giới và đa dạng giới mắc chứng tự kỷ: Thách thức và chiến lược tối ưu hóa tuân thủ https://news.medxy.ai/navigating-gender-affirming-hormone-therapy-in-autistic-transgender-and-gender-diverse-adults-challenges-and-strategies-for-optimal-adherence/Medxy AIen2026-09-11T08:43:48-07:00Navigating Gender-Affirming Hormone Therapy in Autistic Transgender and Gender Diverse Adults: Challenges and Strategies for Optimal Adherence https://news.medxy.ai/zh/congenital-adrenal-hyperplasia-4/Medxy AIzh2026-09-11T08:42:52-07:00先天性肾上腺皮质增生症患者终生住院负担与结局：来自瑞士人群队列研究的启示 https://news.medxy.ai/ja/congenital-adrenal-hyperplasia-3/Medxy AIja2026-09-11T08:42:28-07:00先天性副腎過形成の生涯にわたる入院負担と転帰：スイス集団ベースコホート研究からの知見 https://news.medxy.ai/vi/congenital-adrenal-hyperplasia-2/Medxy AIvi2026-09-11T08:42:02-07:00Gánh nặng nhập viện và kết cục của tăng sản thượng thận bẩm sinh theo suốt vòng đời: Góc nhìn từ một nghiên cứu đoàn hệ dân số Thụy Sĩ https://news.medxy.ai/hospitalization-burden-and-outcomes-in-congenital-adrenal-hyperplasia-across-the-lifespan-insights-from-a-swiss-population-based-cohort-study/Medxy AIen2026-09-11T08:41:38-07:00Hospitalization Burden and Outcomes in Congenital Adrenal Hyperplasia Across the Lifespan: Insights from a Swiss Population-Based Cohort Study https://news.medxy.ai/zh/genetics-macronutrient-preferences/Medxy AIzh2026-09-11T08:40:46-07:00遗传因素如何影响宏量营养素偏好及其对儿童饮食与代谢健康的影响 https://news.medxy.ai/ja/genetic-factors-nutrition/Medxy AIja2026-09-11T08:40:26-07:00三大栄養素の嗜好に関わる遺伝要因と、小児の食事摂取・代謝健康への影響 https://news.medxy.ai/vi/genetics-nutrient-preferences/Medxy AIvi2026-09-11T08:39:59-07:00Di truyền chi phối sở thích chất đa lượng và tác động của chúng lên khẩu phần ăn và sức khỏe chuyển hóa ở trẻ em https://news.medxy.ai/genetic-influences-on-macronutrient-preferences-and-their-impact-on-childhood-food-intake-and-metabolic-health/Medxy AIen2026-09-11T08:39:38-07:00Genetic Influences on Macronutrient Preferences and Their Impact on Childhood Food Intake and Metabolic Health https://news.medxy.ai/zh/colorado-child-autoimmune-rate/Medxy AIzh2026-09-11T08:38:54-07:00科罗拉多儿童胰岛自身免疫发生率上升：中等风险HLA基因型队列的纵向研究新发现 https://news.medxy.ai/vi/pancreatic-autoimmunity-colorado/Medxy AIvi2026-09-11T08:38:05-07:00Tỷ lệ tự miễn đảo tụy ở trẻ Colorado tăng rõ rệt, nổi bật ở nhóm HLA nguy cơ trung bình: dữ liệu từ các đoàn hệ theo dõi dọc https://news.medxy.ai/rising-incidence-of-islet-autoimmunity-among-colorado-children-with-moderate-risk-hla-genotypes-insights-from-longitudinal-cohorts/Medxy AIen2026-09-11T08:37:46-07:00Rising Incidence of Islet Autoimmunity Among Colorado Children With Moderate-Risk HLA Genotypes: Insights From Longitudinal Cohorts https://news.medxy.ai/zh/aspirin-lipoproteina-calcific-aortic-valve-disease/Medxy AIzh2026-09-11T08:37:00-07:00阿司匹林、脂蛋白(a)与钙化性主动脉瓣疾病：来自多种族动脉粥样硬化研究的启示 https://news.medxy.ai/ja/aspirin-lipoprotein-calcium/Medxy AIja2026-09-11T08:36:36-07:00アスピリン、リポ蛋白(a)、石灰化大動脈弁疾患：Multi-Ethnic Study of Atherosclerosisからの知見 https://news.medxy.ai/vi/aspirin-lipoprotein-a-stenosis/Medxy AIvi2026-09-11T08:36:12-07:00Aspirin, lipoprotein(a) và bệnh van động mạch chủ vôi hóa: Những phát hiện từ Nghiên cứu Đa sắc tộc về Xơ vữa động mạch https://news.medxy.ai/aspirin-use-lipoproteina-and-calcific-aortic-valve-disease-insights-from-the-multi-ethnic-study-of-atherosclerosis/Medxy AIen2026-09-11T08:35:50-07:00Aspirin Use, Lipoprotein(a), and Calcific Aortic Valve Disease: Insights from the Multi-Ethnic Study of Atherosclerosis https://news.medxy.ai/zh/hfpef-risk-model/Medxy AIzh2026-09-11T08:34:53-07:00HFpEF 预后评估再升级：LIFE-Preserved 风险预测模型 https://news.medxy.ai/ja/72557-2/Medxy AIja2026-09-11T08:34:32-07:00HFpEFにおける予後評価の進歩：LIFE-Preservedリスク予測モデル https://news.medxy.ai/vi/hfpref-risk-model/Medxy AIvi2026-09-11T08:34:09-07:00Nâng cao độ chính xác tiên lượng trong HFpEF: mô hình dự báo nguy cơ LIFE-Preserved https://news.medxy.ai/advancing-prognostic-precision-in-hfpef-the-life-preserved-risk-prediction-model/Medxy AIen2026-09-11T08:33:49-07:00Advancing Prognostic Precision in HFpEF: The LIFE-Preserved Risk Prediction Model https://news.medxy.ai/zh/air-pollution-heart-health/Medxy AIzh2026-09-11T08:32:58-07:00空气污染如何影响心脏健康：慢性PM2.5暴露与冠状动脉内皮功能障碍 https://news.medxy.ai/ja/pm25-heart-damage/Medxy AIja2026-09-11T08:32:34-07:00大気汚染と心臓をつなぐ：PM2.5 慢性曝露と冠動脈内皮機能障害 https://news.medxy.ai/vi/72545-2/Medxy AIvi2026-09-11T08:32:06-07:00Ô nhiễm không khí ảnh hưởng đến sức khỏe tim mạch như thế nào: Tiếp xúc mãn tính với bụi mịn PM2.5 và rối loạn chức năng nội mô mạch vành https://news.medxy.ai/linking-air-pollution-to-heart-health-chronic-pm2-5-exposure-and-coronary-endothelial-dysfunction/Medxy AIen2026-09-11T08:31:41-07:00Linking Air Pollution to Heart Health: Chronic PM2.5 Exposure and Coronary Endothelial Dysfunction https://news.medxy.ai/zh/pci-long-term-benefits-2/Medxy AIzh2026-09-11T08:30:41-07:00QFR指导PCI的长期获益：来自FAVOR III China 5年随访的证据 https://news.medxy.ai/ja/72533-2/Medxy AIja2026-09-11T08:30:23-07:00QFRガイド下PCIの長期的なベネフィット：FAVOR III China試験の5年追跡調査によるエビデンス https://news.medxy.ai/vi/pci-long-term-benefits/Medxy AIvi2026-09-11T08:30:00-07:00Lợi ích dài hạn của PCI được hướng dẫn bởi Quantitative Flow Ratio: Kết quả 5 năm từ thử nghiệm FAVOR III China https://news.medxy.ai/long-term-benefits-of-quantitative-flow-ratio-guided-pci-insights-from-the-5-year-favor-iii-china-trial/Medxy AIen2026-09-11T08:29:42-07:00Long-Term Benefits of Quantitative Flow Ratio-Guided PCI: Insights from the 5-Year FAVOR III China Trial https://news.medxy.ai/zh/lge-genetic-arrhythmia-risk/Medxy AIzh2026-09-11T08:28:53-07:00超越射血分数：LGE通道与遗传标志物助力非缺血性扩张型心肌病心律失常风险分层 https://news.medxy.ai/ja/nonischemic-cardiomyopathy-arrhythmia/Medxy AIja2026-09-11T08:28:37-07:00非虚血性拡張型心筋症の不整脈リスク層別化を前進させる：LGEコリドーと遺伝学的マーカーの役割 https://news.medxy.ai/vi/arrhythmia-risk-stratification/Medxy AIvi2026-09-11T08:28:17-07:00Nâng cao phân tầng nguy cơ loạn nhịp ở bệnh cơ tim giãn không do thiếu máu cục bộ: Vai trò của hành lang LGE và dấu ấn di truyền https://news.medxy.ai/advancing-arrhythmic-risk-stratification-in-nonischemic-dilated-cardiomyopathy-the-role-of-lge-corridors-and-genetic-markers/Medxy AIen2026-09-11T08:27:55-07:00Advancing Arrhythmic Risk Stratification in Nonischemic Dilated Cardiomyopathy: The Role of LGE Corridors and Genetic Markers https://news.medxy.ai/zh/macrotroponin-cardiovascular-risk-2/Medxy AIzh2026-09-11T08:27:07-07:00Macrotroponin 复合物与心血管事件风险：心脏肌钙蛋白检测在人群风险分层中的意义 https://news.medxy.ai/ja/macrotroponin-cardiovascular-risk/Medxy AIja2026-09-11T08:26:40-07:00Macrotroponin複合体と心血管イベントリスク：集団リスク層別化における心筋トロポニン検査への示唆 https://news.medxy.ai/vi/macrotroponin-cardiac-risk/Medxy AIvi2026-09-11T08:26:11-07:00Phức hợp macrotroponin và nguy cơ biến cố tim mạch: Hàm ý đối với xét nghiệm troponin tim trong phân tầng nguy cơ quần thể https://news.medxy.ai/macrotroponin-complexes-and-risk-of-cardiovascular-events-implications-for-cardiac-troponin-testing-in-population-risk-stratification/Medxy AIen2026-09-11T08:25:48-07:00Macrotroponin Complexes and Risk of Cardiovascular Events: Implications for Cardiac Troponin Testing in Population Risk Stratification https://news.medxy.ai/zh/internal-medicine-care/Medxy AIzh2026-09-10T08:34:47-07:00强化内科住院医师就诊间照护：结构支持与教育课程的整合实践 https://news.medxy.ai/ja/72156-2/Medxy AIja2026-09-10T08:34:31-07:00内科レジデンシーにおける受診間ケアの強化 https://news.medxy.ai/vi/improving-internal-medicine-care/Medxy AIvi2026-09-10T08:34:13-07:00Nâng cao chăm sóc giữa các lần khám trong đào tạo nội trú Nội khoa: Kết hợp hỗ trợ cơ cấu và chương trình giáo dục https://news.medxy.ai/enhancing-inter-visit-care-in-internal-medicine-residency-integrating-structural-support-and-educational-curriculum/Medxy AIen2026-09-10T08:33:57-07:00Enhancing Inter-Visit Care in Internal Medicine Residency: Integrating Structural Support and Educational Curriculum https://news.medxy.ai/zh/72148-2/Medxy AIzh2026-09-10T08:33:24-07:00居住在疗养院的 Medicare 受益人中呼吸道合胞病毒疫苗的有效性 https://news.medxy.ai/ja/72147-2/Medxy AIja2026-09-10T08:33:07-07:00介護施設に入居するメディケア受給者におけるRSウイルスワクチンの有効性 https://news.medxy.ai/vi/72146-2/Medxy AIvi2026-09-10T08:32:48-07:00Hiệu quả của vắc-xin phòng vi-rút hợp bào hô hấp ở những người thụ hưởng Medicare sống tại các viện dưỡng lão https://news.medxy.ai/respiratory-syncytial-virus-vaccine-effectiveness-in-medicare-beneficiaries-residing-in-nursing-homes-a-comprehensive-review/Medxy AIen2026-09-10T08:32:30-07:00Respiratory Syncytial Virus Vaccine Effectiveness in Medicare Beneficiaries Residing in Nursing Homes: A Comprehensive Review https://news.medxy.ai/zh/parental-vitamin-b12-folic-acid-birth-defects/Medxy AIzh2026-09-10T08:30:10-07:00父母围受孕期维生素B12与叶酸水平越高，出生缺陷风险越低：大型前瞻性队列研究新发现 https://news.medxy.ai/ja/vitamin-b12-folic-acid-birth-defects/Medxy AIja2026-09-10T08:29:53-07:00受胎前後の親のビタミンB12・葉酸が出生異常リスク低下と関連：大規模前向きコホート研究の知見 https://news.medxy.ai/vi/72141-2/Medxy AIvi2026-09-10T08:29:35-07:00Nồng độ vitamin B12 và axit folic càng cao vào thời điểm thụ thai thì nguy cơ dị tật bẩm sinh càng thấp https://news.medxy.ai/periconceptional-vitamin-b12-and-folate-levels-in-parents-linked-to-birth-defect-risk-reduction-insights-from-a-large-prospective-cohort/Medxy AIen2026-09-10T08:29:17-07:00Periconceptional Vitamin B12 and Folate Levels in Parents Linked to Birth Defect Risk Reduction: Insights from a Large Prospective Cohort https://news.medxy.ai/zh/tp53-mutations-aml/Medxy AIzh2026-09-10T08:28:40-07:00急性髓系白血病中的TP53突变：对同种异基因造血细胞移植后结局的影响 https://news.medxy.ai/ja/tp53-mutation-aml/Medxy AIja2026-09-10T08:28:24-07:00急性骨髄性白血病におけるTP53変異：同種造血細胞移植後転帰への影響 https://news.medxy.ai/vi/tp53-mutations-leukemia/Medxy AIvi2026-09-10T08:28:06-07:00Đột biến TP53 trong bệnh bạch cầu cấp dòng tủy: Tác động lên kết cục sau ghép tế bào tạo máu đồng loài https://news.medxy.ai/tp53-mutations-in-acute-myeloid-leukemia-impact-on-outcomes-post-allogeneic-hematopoietic-cell-transplantation/Medxy AIen2026-09-10T08:27:45-07:00TP53 Mutations in Acute Myeloid Leukemia: Impact on Outcomes Post-Allogeneic Hematopoietic Cell Transplantation https://news.medxy.ai/zh/kmt2a-ptd-mrd/Medxy AIzh2026-09-10T08:27:03-07:00移植前KMT2A-PTD可测量残留病：急性髓系白血病预后分层的新标志物 https://news.medxy.ai/ja/kmt2a-ptd-mrd-marker/Medxy AIja2026-09-10T08:26:47-07:00AMLにおける移植前KMT2A-PTD MRD：予後予測バイオマーカーとしての意義 https://news.medxy.ai/vi/kmt2a-ptd-transplant/Medxy AIvi2026-09-10T08:26:28-07:00KMT2A-PTD trước ghép: dấu ấn tiên lượng đáng chú ý trong ghép tế bào gốc đồng loài ở bệnh bạch cầu tủy cấp https://news.medxy.ai/pre-transplant-kmt2a-ptd-measurable-residual-disease-as-a-prognostic-biomarker-in-acute-myeloid-leukemia-allogeneic-stem-cell-transplantation/Medxy AIen2026-09-10T08:26:11-07:00Pre-Transplant KMT2A-PTD Measurable Residual Disease as a Prognostic Biomarker in Acute Myeloid Leukemia Allogeneic Stem Cell Transplantation https://news.medxy.ai/zh/clonal-hematopoiesis-afa/Medxy AIzh2026-09-10T08:25:36-07:00再生障碍性贫血免疫抑制治疗中的克隆性造血演变：研究发现与临床启示 https://news.medxy.ai/ja/aplastic-anemia-clonality/Medxy AIja2026-09-10T08:25:19-07:00再生不良性貧血におけるクローン性造血の変化：免疫抑制療法下の患者で見えた動態と臨床的意義 https://news.medxy.ai/vi/hematopoiesis-aplasia-treatment/Medxy AIvi2026-09-10T08:24:59-07:00Động học tạo máu dòng vô tính ở bệnh nhân thiếu máu bất sản điều trị ức chế miễn dịch: Những điểm mới và ý nghĩa lâm sàng https://news.medxy.ai/clonal-hematopoiesis-dynamics-in-aplastic-anemia-patients-undergoing-immunosuppressive-therapy-insights-and-clinical-implications/Medxy AIen2026-09-10T08:24:39-07:00Clonal Hematopoiesis Dynamics in Aplastic Anemia Patients Undergoing Immunosuppressive Therapy: Insights and Clinical Implications https://news.medxy.ai/zh/triple-gene-knockout-car-t/Medxy AIzh2026-09-10T08:24:05-07:00CT0590：三重基因敲除异体 BCMA CAR T 疗法推动多发性骨髓瘤与浆细胞白血病治疗进展 https://news.medxy.ai/ja/triple-knockout-car-t/Medxy AIja2026-09-10T08:23:48-07:00CT0590：三重ノックアウト同種異系BCMA CAR T療法が多発性骨髄腫と形質細胞白血病の治療を前進させる https://news.medxy.ai/vi/car-t-therapy-multiple-myeloma/Medxy AIvi2026-09-10T08:23:25-07:00CT0590: Liệu pháp CAR T dị gen BCMA loại bỏ ba gen mở ra hướng điều trị mới cho đa u tủy xương và bạch cầu tương bào https://news.medxy.ai/ct0590-a-triple-knockout-allogeneic-bcma-car-t-therapy-advances-treatment-in-multiple-myeloma-and-plasma-cell-leukemia/Medxy AIen2026-09-10T08:23:04-07:00CT0590: A Triple-Knockout Allogeneic BCMA CAR T Therapy Advances Treatment in Multiple Myeloma and Plasma Cell Leukemia https://news.medxy.ai/zh/copd-lung-cancer-screening/Medxy AIzh2026-09-10T08:22:19-07:00肺癌筛查中的COPD识别新路径：整合定量CT生物标志物提升检出效率 https://news.medxy.ai/ja/copd-detection-lung-cancer/Medxy AIja2026-09-10T08:22:03-07:00肺がん検診におけるCOPD検出を高める：定量的CTバイオマーカー統合の有用性 https://news.medxy.ai/vi/copd-detection-biomarkers/Medxy AIvi2026-09-10T08:21:44-07:00Tăng cường phát hiện COPD nhờ các dấu ấn sinh học CT định lượng tích hợp trong chương trình sàng lọc ung thư phổi https://news.medxy.ai/enhancing-copd-detection-through-integrated-quantitative-ct-biomarkers-in-lung-cancer-screening-programs/Medxy AIen2026-09-10T08:21:24-07:00Enhancing COPD Detection through Integrated Quantitative CT Biomarkers in Lung Cancer Screening Programs https://news.medxy.ai/zh/early-pvod-pch-detection/Medxy AIzh2026-09-10T08:20:41-07:00肺动脉高压中 PVOD/PCH 的早期识别：一种新型临床似然评分的建立 https://news.medxy.ai/ja/pvod-pch-early-detection/Medxy AIja2026-09-10T08:20:26-07:00肺動脈性肺高血圧症における PVOD/PCH の早期同定：新規臨床的発症確率スコアの提案 https://news.medxy.ai/vi/early-pvod-pch-detection-2/Medxy AIvi2026-09-10T08:20:07-07:00Phát hiện sớm PVOD/PCH trong tăng áp động mạch phổi: giới thiệu một thang điểm xác suất lâm sàng mới https://news.medxy.ai/early-identification-of-pvod-pch-in-pulmonary-arterial-hypertension-introducing-a-novel-clinical-likelihood-score/Medxy AIen2026-09-10T08:19:49-07:00Early Identification of PVOD/PCH in Pulmonary Arterial Hypertension: Introducing a Novel Clinical Likelihood Score https://news.medxy.ai/zh/diabetic-macular-edema-trial/Medxy AIzh2026-09-10T08:19:13-07:00突破试验门槛：糖尿病黄斑水肿患者抗VEGF临床试验资格的现实世界评估及其临床与公平性启示 https://news.medxy.ai/ja/diabetic-macular-edema-vegf/Medxy AIja2026-09-10T08:18:56-07:00糖尿病黄斑浮腫における抗VEGF試験の実臨床適格性：臨床実践と健康公平性への示唆 https://news.medxy.ai/vi/diabetic-macular-edema-anti-vegf/Medxy AIvi2026-09-10T08:18:34-07:00Mức độ phù hợp trong thực tế của bệnh nhân phù hoàng điểm do đái tháo đường đối với các thử nghiệm anti-VEGF: Hệ quả đối với thực hành lâm sàng và công bằng y tế https://news.medxy.ai/real-world-eligibility-of-diabetic-macular-edema-patients-for-anti-vegf-trials-implications-for-clinical-practice-and-health-equity/Medxy AIen2026-09-10T08:18:16-07:00Real-World Eligibility of Diabetic Macular Edema Patients for Anti-VEGF Trials: Implications for Clinical Practice and Health Equity https://news.medxy.ai/zh/socioeconomic-deprivation-impact-2/Medxy AIzh2026-09-10T08:17:39-07:00社区社会经济剥夺如何加重声音与反流症状负担：来自三级喉科学门诊的研究 https://news.medxy.ai/ja/socioeconomic-deprivation-impact/Medxy AIja2026-09-10T08:17:21-07:00地域の社会経済的剥奪は声と逆流症状の負担をどう高めるか：三次喉頭科外来からの知見 https://news.medxy.ai/vi/72075-2/Medxy AIvi2026-09-10T08:17:04-07:00Ảnh hưởng của tình trạng thiếu hụt về kinh tế – xã hội tại khu dân cư đến gánh nặng triệu chứng giọng nói và trào ngược: Những hiểu biết từ một phòng khám chuyên khoa thanh quản tuyến cuối https://news.medxy.ai/impact-of-neighborhood-socioeconomic-deprivation-on-voice-and-reflux-symptom-burden-insights-from-a-tertiary-laryngology-clinic/Medxy AIen2026-09-10T08:16:46-07:00Impact of Neighborhood Socioeconomic Deprivation on Voice and Reflux Symptom Burden: Insights from a Tertiary Laryngology Clinic https://news.medxy.ai/zh/minimally-invasive-vs-open-hepatobiliary-surgery/Medxy AIzh2026-09-10T08:16:06-07:00微创与开放肝胆胰外科手术的经济学与患者中心结局：一项为期1年的比较研究 https://news.medxy.ai/ja/72071-2/Medxy AIja2026-09-10T08:15:47-07:00肝胆膵外科における低侵襲手術と開腹手術の経済性および患者中心の転帰：1年間の比較研究 https://news.medxy.ai/vi/minimally-invasive-vs-open-surgery/Medxy AIvi2026-09-10T08:15:28-07:00Phẫu thuật gan-mật-tụy xâm lấn tối thiểu và phẫu thuật mở: So sánh 1 năm về hiệu quả kinh tế và kết cục lấy bệnh nhân làm trung tâm https://news.medxy.ai/economic-and-patient-centered-outcomes-of-minimally-invasive-versus-open-hepatopancreatobiliary-surgery-a-one-year-comparative-study/Medxy AIen2026-09-10T08:15:07-07:00Economic and Patient-centered Outcomes of Minimally Invasive versus Open Hepatopancreatobiliary Surgery: A One-Year Comparative Study